Dr. Gordon Spencer Huggins, MD

Dr. Huggins practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Huggins' NPI, 1255345559, was assigned on July 29, 2006. Dr. Huggins graduated from University of Chicago, Pritzker School of Medicine in 1990. Dr. Huggins holds Massachusetts license 75842.

Dr. Huggins' primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Huggins' primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Huggins is also affiliated with South Shore Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Huggins to 3 more hospitals, 5 medical groups, 1 group practice or clinic and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huggins practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Huggins' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Huggins is licensed in Massachusetts.

CMS data shows 2,189 Medicare services from Dr. Huggins across 7 procedure codes in 2024, for 1,354 Medicare patients. Medicare paid $46,133 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,354 Medicare patients who saw Dr. Huggins in 2024. The largest group is 65 to 74, with 493 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Huggins' median patient age at 61, with 46% women.

In 2024, Dr. Huggins wrote 70 Medicare Part D claims for 12 patients. 60% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $9,673 in total drug cost. In 2022, CMS named 53 claims across 3 drugs.

Dr. Huggins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 78 papers to Dr. Huggins, published from 2010 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Heart Failure, Polymorphism, Single Nucleotide and Cardiomyopathy, Dilated. Dr. Huggins has published most often in Pharmacogenomics J. Dr. Huggins' most frequent co-authors are Ray Elwin Hershberger, MD, Anjali T. Owens, MD and Daniel P. Judge, MD.

Dmand AI links Dr. Huggins to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Cardiomyopathy, Dilated, Heart Failure and Heart Diseases.

CMS Open Payments shows 5 general payments to Dr. Huggins from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $131. It also lists 2 research payments totaling $128 in 2024.

Dr. Huggins graduated from University of Chicago, Pritzker School of Medicine in 1990.